Diarrhea Prevalence, Care, and Risk Factors Among Poor Children Under 5 Years of Age in Mesoamerica

The American Journal of Tropical Medicine and Hygiene
Danny V ColombaraAli H Mokdad

Abstract

Care practices and risk factors for diarrhea among impoverished communities across Mesoamerica are unknown. Using Salud Mesoamérica Initiative baseline data, collected 2011-2013, we assessed the prevalence of diarrhea, adherence to evidence-based treatment guidelines, and potential diarrhea correlates in poor and indigenous communities across Mesoamerica. This study surveyed 14,500 children under 5 years of age in poor areas of El Salvador, Guatemala, Mexico (Chiapas State), Nicaragua, and Panama. We compared diarrhea prevalence and treatment modalities using χ(2) tests and used multivariable Poisson regression models to calculate adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) for potential correlates of diarrhea. The 2-week point prevalence of diarrhea was 13% overall, with significant differences between countries (P < 0.05). Approximately one-third of diarrheal children were given oral rehydration solution and less than 3% were given zinc. Approximately 18% were given much less to drink than usual or nothing to drink at all. Antimotility medication was given to 17% of diarrheal children, while antibiotics were inappropriately given to 36%. In a multivariable regression model, compared with children 0-5 months...Continue Reading

References

Apr 1, 1991·The Journal of Pediatrics·M Santosham, W B Greenough
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
May 1, 2004·American Journal of Public Health·Adam WagstaffUNKNOWN WHO-World Bank Child Health and Poverty Working Group
Oct 27, 2004·The Pediatric Infectious Disease Journal·F Raúl VelázquezPablo Kuri
Dec 6, 2008·International Journal of Epidemiology·Karen LevyJoseph N S Eisenberg
Oct 14, 2009·The Journal of Infectious Diseases·Lucia Helena de OliveiraUNKNOWN Rotavirus Surveillance Network
Apr 2, 2010·International Journal of Epidemiology·Melinda K MunosRobert E Black
Jul 9, 2010·Lancet·Mathuram SantoshamRobert Black
Oct 1, 2010·The Pediatric Infectious Disease Journal·Sylvia Becker-DrepsFélix Espinoza
Feb 17, 2015·Population Health Metrics·Ali H MokdadFerdinando Regalia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Journal of Nutrition
Danny V ColombaraAli H Mokdad
Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Marianela RojasFernando G Benavides
Zhonghua hu li za zhi = Chinese journal of nursing
L G Yan
JAMA : the Journal of the American Medical Association
© 2022 Meta ULC. All rights reserved